Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2Anna Vihola, Bjarne Udd, Anders Paetau et al.|Neurology|2003Cited by 173
XRCC1 and XRCC3 variants and risk of glioma and meningiomaAnne Kiuru, Anssi Auvinen, Carita Lindholm et al.|Journal of Neuro-Oncology|2008Cited by 82
Mutant (CCTG)n Expansion Causes Abnormal Expression of Zinc Finger Protein 9 (ZNF9) in Myotonic Dystrophy Type 2Olayinka Raheem, Ralf Krahe, Shodimu-Emmanuel Olufemi et al.|American Journal Of Pathology|2010Cited by 75
Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2Anna Vihola, Bjarne Udd, Linda L. Bachinski et al.|Acta Neuropathologica|2010Cited by 73
New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2)Riitta Sallinen, Bjarne Udd, Anna Vihola et al.|Neuromuscular Disorders|2004Cited by 45